The trial will measure the number of patients in each arm whove achieved at least 25% or 30% weight reduction at the end of treatment
STIMULATE COGNITIVE HEALTH AND BRAIN FUNCTION
The full treatment cycle usually runs 12-16 weeks, followed by a break period before potential additional cycles
Compounded medications are prepared by licensed pharmacies and are not FDA-approved
Early studies in obese individuals showed some reductions in body fat mass, but findings are not consistent across trials: In one clinical trial, AOD9604 did not demonstrate statistically significant weight loss compared to placebo, suggesting its fat-burning effects may be modest without lifestyle intervention (summary of trials)
Crucially, that filing is for CagriSema, not for standalone cagrilintide, and no version is approved yet